Catalent, founded in 2007, is a global leader in providing advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The company's headquarters are located in Somerset, New Jersey, USA. Catalent plays a crucial role in the pharmaceutical and biotechnology industries, offering services like drug formulation, manufacturing, packaging, and clinical supply services. Catalent has a substantial global workforce with over 15,000 employees dedicated to advancing healthcare through innovation.

Financially, Catalent has demonstrated robust performance, reflecting its essential role in the pharmaceutical and biotech sectors. As of June 30, 2023, Catalent had $4.85 billion in total debt, and $4.57 billion in total debt net of cash, cash equivalents, and marketable securities.